A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Tuesday 1 February 2011

More on that Dutch Advair litigation

Further to The SPC Blog's post earlier today on GSK's loss of its Advair patent and SPC (here), thanks are owed to Peter Burgers (Brinkhof) for providing us with a full 21-page translation of the decision. You can read it here.

Peter has also drawn our attention to a note on this decision that was posted on the Kluwer Patent Blog here last Wednesday by his colleague Rik Lambers.

No comments: